Targeting liver X receptors in human health: deadlock or promising trail?

Bibliography

• Repa JJ, Mangelsdorf DJ. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu Rev Cell Dev Biol 2000;16:459-81
   PubMed Web of Science ®Google Scholar
• Willy PJ, Umesono K, Ong ES, LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev 1995;9:1033-45
   PubMed Web of Science ®Google Scholar
• Janowski BA, Willy PJ, Devi TR, An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 1996;383:728-31
   PubMed Web of Science ®Google Scholar
• Repa JJ, Berge KE, Pomajzl C, Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J Biol Chem 2002;277:18793-800
   PubMed Web of Science ®Google Scholar
• Nuclear Receptors Signaling Atlas. Bethesda, MD: Nuclear Receptors Signaling Atlas consortium, 2003 – 2010 Available from: www.nursa.org [Last accessed 14 December 2010]
   Google Scholar
• Souidi M, Dubrac S, Parquet M, Oxysterols: metabolism, biological role and associated diseases. Gastroenterol Clin Biol 2004;28:279-93
   PubMedGoogle Scholar
• Lehmann JM, Kliewer SA, Moore LB, Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J Biol Chem 1997;272:3137-40
   PubMed Web of Science ®Google Scholar
• Li X, Zhang S, Blander G, SIRT1 deacetylates and positively regulates the nuclear receptor LXR. Mol Cell 2007;28:91-106
   PubMed Web of Science ®Google Scholar
• Hu X, Li S, Wu J, Liver X receptors interact with corepressors to regulate gene expression. Mol Endocrinol 2003;17:1019-26
   PubMed Web of Science ®Google Scholar
• Lazar MA. Nuclear receptor corepressors. Nucl Recept Signal 2003;1:e001
   PubMedGoogle Scholar
• Lee S, Lee J, Lee SK, Activating signal cointegrator-2 is an essential adaptor to recruit histone H3 lysine 4 methyltransferases MLL3 and MLL4 to the liver X receptors. Mol Endocrinol 2008;22:1312-19
   PubMedGoogle Scholar
• Svensson S, Ostberg T, Jacobsson M, Crystal structure of the heterodimeric complex of LXRalpha and RXRbeta ligand-binding domains in a fully agonistic conformation. EMBO J 2003;22:4625-33
   PubMed Web of Science ®Google Scholar
• Schroepfer GJ Jr. Oxysterols: modulators of cholesterol metabolism and other processes. Physiol Rev 2000;80:361-554
   PubMed Web of Science ®Google Scholar
• Bjorkhem I. Are side-chain oxidized oxysterols regulators also in vivo? J Lipid Res 2009;50(Suppl):S213-18
   Google Scholar
• Yang C, McDonald JG, Patel A, Sterol intermediates from cholesterol biosynthetic pathway as liver X receptor ligands. J Biol Chem 2006;281:27816-26
   PubMed Web of Science ®Google Scholar
• Song C, Hiipakka RA, Liao S. Selective activation of liver X receptor alpha by 6alpha-hydroxy bile acids and analogs. Steroids 2000;65:423-7
   PubMed Web of Science ®Google Scholar
• Ondeyka JG, Jayasuriya H, Herath KB, Steroidal and triterpenoidal fungal metabolites as ligands of liver X receptors. J Antibiot (Tokyo) 2005;58:559-65
   PubMed Web of Science ®Google Scholar
• Jayasuriya H, Herath KB, Ondeyka JG, Diterpenoid, steroid, and triterpenoid agonists of liver X receptors from diversified terrestrial plants and marine sources. J Nat Prod 2005;68:1247-52
   PubMed Web of Science ®Google Scholar
• Huang TH, Razmovski-Naumovski V, Salam NK, A novel LXR-alpha activator identified from the natural product Gynostemma pentaphyllum. Biochem Pharmacol 2005;70:1298-308
   PubMed Web of Science ®Google Scholar
• Li X, Yeh V, Molteni V. Liver X receptor modulators: a review of recently patented compounds (2007 – 2009). Expert Opin Ther Pat 2010;20:535-62
   PubMed Web of Science ®Google Scholar
• Schultz JR, Tu H, Luk A, Role of LXRs in control of lipogenesis. Genes Dev 2000;14:2831-8
   PubMed Web of Science ®Google Scholar
• Collins JL, Fivush AM, Watson MA, Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines. J Med Chem 2002;45:1963-6
   PubMed Web of Science ®Google Scholar
• Houck KA, Borchert KM, Hepler CD, T0901317 is a dual LXR/FXR agonist. Mol Genet Metab 2004;83:184-7
   PubMed Web of Science ®Google Scholar
• Shenoy SD, Spencer TA, Mercer-Haines NA, CYP3A induction by liver X receptor ligands in primary cultured rat and mouse hepatocytes is mediated by the pregnane X receptor. Drug Metab Dispos 2004;32:66-71
   PubMed Web of Science ®Google Scholar
• Mitro N, Vargas L, Romeo R, T0901317 is a potent PXR ligand: implications for the biology ascribed to LXR. FEBS Lett 2007;581:1721-6
   PubMed Web of Science ®Google Scholar
• Joseph SB, Laffitte BA, Patel PH, Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors. J Biol Chem 2002;277:11019-25
   PubMed Web of Science ®Google Scholar
• Lund EG, Peterson LB, Adams AD, Different roles of liver X receptor alpha and beta in lipid metabolism: effects of an alpha-selective and a dual agonist in mice deficient in each subtype. Biochem Pharmacol 2006;71:453-63
   PubMed Web of Science ®Google Scholar
• Bradley MN, Hong C, Chen M, Ligand activation of LXRbeta reverses atherosclerosis and cellular cholesterol overload in mice lacking LXRalpha and apoE. J Clin Invest 2007;117:2337-46
   PubMed Web of Science ®Google Scholar
• Kaneko E, Matsuda M, Yamada Y, Induction of intestinal ATP-binding cassette transporters by a phytosterol-derived liver X receptor agonist. J Biol Chem 2003;278:36091-8
   PubMed Web of Science ®Google Scholar
• Yasuda T, Grillot D, Billheimer JT, Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo. Arterioscler Thromb Vasc Biol 2010;30:781-6
   PubMed Web of Science ®Google Scholar
• Katz A, Udata C, Ott E, Safety, pharmacokinetics, and pharmacodynamics of single doses of LXR-623, a novel liver X-receptor agonist, in healthy participants. J Clin Pharmacol 2009;49:643-9
   PubMed Web of Science ®Google Scholar
• DiBlasio-Smith EA, Arai M, Quinet EM, Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells. J Transl Med 2008;6:59
   PubMed Web of Science ®Google Scholar
• Hu B, Unwalla RJ, Goljer I, Identification of phenylsulfone-substituted quinoxaline (WYE-672) as a tissue selective liver X-receptor (LXR) agonist. J Med Chem 2010;53:3296-304
   PubMed Web of Science ®Google Scholar
• Yoshikawa T, Shimano H, Yahagi N, Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements. J Biol Chem 2002;277:1705-11
   PubMed Web of Science ®Google Scholar
• Ou J, Tu H, Shan B, Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proc Natl Acad Sci USA 2001;98:6027-32
   PubMed Web of Science ®Google Scholar
• Qin Y, Dalen KT, Gustafsson JA, Regulation of hepatic fatty acid elongase 5 by LXRalpha-SREBP-1c. Biochim Biophys Acta 2009;1791:140-7
   PubMed Web of Science ®Google Scholar
• Herath K, Jayasuriya H, Ondeyka JG, Guttiferone I, a new prenylated benzophenone from Garcinia humilis as a liver X receptor ligand. J Nat Prod 2005;68:617-9
   PubMed Web of Science ®Google Scholar
• Tamehiro N, Sato Y, Suzuki T, Riccardin C: a natural product that functions as a liver X receptor (LXR)alpha agonist and an LXRbeta antagonist. FEBS Lett 2005;579:5299-304
   PubMed Web of Science ®Google Scholar
• Janowski BA, Grogan MJ, Jones SA, Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. Proc Natl Acad Sci USA 1999;96:266-71
   PubMed Web of Science ®Google Scholar
• Thomas J, Bramlett KS, Montrose C, A chemical switch regulates fibrate specificity for peroxisome proliferator-activated receptor alpha (PPARalpha) versus liver X receptor. J Biol Chem 2003;278:2403-10
   PubMed Web of Science ®Google Scholar
• Kliewer SA, Lehmann JM, Willson TM. Orphan nuclear receptors: shifting endocrinology into reverse. Science 1999;284:757-60
   PubMed Web of Science ®Google Scholar
• Peet DJ, Turley SD, Ma W, Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXRalpha. Cell 1998;93:693-704
   PubMed Web of Science ®Google Scholar
• Chiang JY, Kimmel R, Stroup D. Regulation of cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRalpha). Gene 2001;262:257-65
   PubMed Web of Science ®Google Scholar
• Brooks-Wilson A, Marcil M, Clee SM, Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 1999;22:336-45
   PubMed Web of Science ®Google Scholar
• Hubacek JA, Berge KE, Cohen JC, Mutations in ATP-cassette binding proteins G5 (ABCG5) and G8 (ABCG8) causing sitosterolemia. Hum Mutat 2001;18:359-60
   PubMedGoogle Scholar
• Costet P, Luo Y, Wang N, Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J Biol Chem 2000;275:28240-5
   PubMed Web of Science ®Google Scholar
• Kennedy MA, Venkateswaran A, Tarr PT, Characterization of the human ABCG1 gene: liver X receptor activates an internal promoter that produces a novel transcript encoding an alternative form of the protein. J Biol Chem 2001;276:39438-47
   PubMed Web of Science ®Google Scholar
• Laffitte BA, Repa JJ, Joseph SB, LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc Natl Acad Sci USA 2001;98:507-12
   PubMed Web of Science ®Google Scholar
• Repa JJ, Liang G, Ou J, Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev 2000;14:2819-30
   PubMed Web of Science ®Google Scholar
• Cha JY, Repa JJ. The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR. J Biol Chem 2007;282:743-51
   PubMed Web of Science ®Google Scholar
• Denechaud PD, Bossard P, Lobaccaro JM, ChREBP, but not LXRs, is required for the induction of glucose-regulated genes in mouse liver. J Clin Invest 2008;118:956-64
   PubMed Web of Science ®Google Scholar
• Laffitte BA, Chao LC, Li J, Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. Proc Natl Acad Sci USA 2003;100:5419-24
   PubMed Web of Science ®Google Scholar
• Efanov AM, Sewing S, Bokvist K, Liver X receptor activation stimulates insulin secretion via modulation of glucose and lipid metabolism in pancreatic beta-cells. Diabetes 2004;53(Suppl 3):S75-8
   Google Scholar
• Ogihara T, Chuang JC, Vestermark GL, Liver X receptor agonists augment human islet function through activation of anaplerotic pathways and glycerolipid/free fatty acid cycling. J Biol Chem 2010;285:5392-404
   PubMed Web of Science ®Google Scholar
• Gerin I, Dolinsky VW, Shackman JG, LXRbeta is required for adipocyte growth, glucose homeostasis, and beta cell function. J Biol Chem 2005;280:23024-31
   PubMed Web of Science ®Google Scholar
• Zitzer H, Wente W, Brenner MB, Sterol regulatory element-binding protein 1 mediates liver X receptor-beta-induced increases in insulin secretion and insulin messenger ribonucleic acid levels. Endocrinology 2006;147:3898-905
   PubMed Web of Science ®Google Scholar
• Cummins CL, Volle DH, Zhang Y, Liver X receptors regulate adrenal cholesterol balance. J Clin Invest 2006;116:1902-12
   PubMed Web of Science ®Google Scholar
• Volle DH, Mouzat K, Duggavathi R, Multiple roles of the nuclear receptors for oxysterols liver X receptor to maintain male fertility. Mol Endocrinol 2007;21:1014-27
   PubMedGoogle Scholar
• Robertson KM, Schuster GU, Steffensen KR, The liver X receptor-beta is essential for maintaining cholesterol homeostasis in the testis. Endocrinology 2005;146:2519-30
   PubMed Web of Science ®Google Scholar
• Mouzat K, Volat F, Baron S, Absence of nuclear receptors for oxysterols liver X receptor induces ovarian hyperstimulation syndrome in mice. Endocrinology 2009;150:3369-75
   PubMed Web of Science ®Google Scholar
• Joseph SB, Castrillo A, Laffitte BA, Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med 2003;9:213-9
   PubMed Web of Science ®Google Scholar
• Castrillo A, Joseph SB, Marathe C, Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages. J Biol Chem 2003;278:10443-9
   PubMed Web of Science ®Google Scholar
• Castrillo A, Joseph SB, Vaidya SA, Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Mol Cell 2003;12:805-16
   PubMed Web of Science ®Google Scholar
• Fontaine C, Rigamonti E, Pourcet B, The nuclear receptor Rev-erbalpha is a liver X receptor (LXR) target gene driving a negative feedback loop on select LXR-induced pathways in human macrophages. Mol Endocrinol 2008;22:1797-811
   PubMedGoogle Scholar
• Ogawa D, Stone JF, Takata Y, Liver x receptor agonists inhibit cytokine-induced osteopontin expression in macrophages through interference with activator protein-1 signaling pathways. Circ Res 2005;96:e59-67
   PubMed Web of Science ®Google Scholar
• Joseph SB, McKilligin E, Pei L, Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc Natl Acad Sci U S A 2002;99:7604-9
   PubMed Web of Science ®Google Scholar
• Lo Sasso G, Murzilli S, Salvatore L, Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis. Cell Metab 2010;12:187-93
   PubMed Web of Science ®Google Scholar
• Quinet EM, Basso MD, Halpern AR, LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse. J Lipid Res 2009;50:2358-70
   PubMed Web of Science ®Google Scholar
• Dave VP, Kaul D, Sharma Y, Functional genomics of blood cellular LXR-alpha gene in human coronary heart disease. J Mol Cell Cardiol 2009;46:536-44
   PubMed Web of Science ®Google Scholar
• Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab 2008;93:S9-S30
   PubMed Web of Science ®Google Scholar
• Cao G, Liang Y, Broderick CL, Antidiabetic action of a liver X receptor agonist mediated by inhibition of hepatic gluconeogenesis. J Biol Chem 2003;278:1131-6
   PubMed Web of Science ®Google Scholar
• Kase ET, Wensaas AJ, Aas V, Skeletal muscle lipid accumulation in type 2 diabetes may involve the liver X receptor pathway. Diabetes 2005;54:1108-15
   PubMed Web of Science ®Google Scholar
• Dahlman I, Nilsson M, Jiao H, Liver X receptor gene polymorphisms and adipose tissue expression levels in obesity. Pharmacogenet Genomics 2006;16:881-9
   PubMed Web of Science ®Google Scholar
• Martin M, Dotti CG, Ledesma MD. Brain cholesterol in normal and pathological aging. Biochim Biophys Acta 2010;1801:934-44
   PubMed Web of Science ®Google Scholar
• Jick H, Zornberg GL, Jick SS, Statins and the risk of dementia. Lancet 2000;356:1627-31
   PubMed Web of Science ®Google Scholar
• Wolozin B, Kellman W, Ruosseau P, Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 2000;57:1439-43
   PubMed Web of Science ®Google Scholar
• Koldamova RP, Lefterov IM, Staufenbiel M, The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer's disease. J Biol Chem 2005;280:4079-88
   PubMed Web of Science ®Google Scholar
• Zelcer N, Khanlou N, Clare R, Attenuation of neuroinflammation and Alzheimer's disease pathology by liver X receptors. Proc Natl Acad Sci USA 2007;104:10601-6
   PubMed Web of Science ®Google Scholar
• Fitz NF, Cronican A, Pham T, Liver X receptor agonist treatment ameliorates amyloid pathology and memory deficits caused by high-fat diet in APP23 mice. J Neurosci 2010;30:6862-72
   PubMed Web of Science ®Google Scholar
• Wang Y, Rogers PM, Stayrook KR, The selective Alzheimer's disease indicator-1 gene (Seladin-1/DHCR24) is a liver X receptor target gene. Mol Pharmacol 2008;74:1716-21
   PubMed Web of Science ®Google Scholar
• Adighibe O, Arepalli S, Duckworth J, Genetic variability at the LXR gene (NR1H2) may contribute to the risk of Alzheimer's disease. Neurobiol Aging 2006;27:1431-4
   PubMed Web of Science ®Google Scholar
• Infante J, Rodriguez-Rodriguez E, Mateo I, Gene-gene interaction between heme oxygenase-1 and liver X receptor-beta and Alzheimer's disease risk. Neurobiol Aging 2010;31:710-14
   PubMed Web of Science ®Google Scholar
• Komuves LG, Schmuth M, Fowler AJ, Oxysterol stimulation of epidermal differentiation is mediated by liver X receptor-beta in murine epidermis. J Invest Dermatol 2002;118:25-34
   PubMed Web of Science ®Google Scholar
• Hanley K, Ng DC, He SS, Oxysterols induce differentiation in human keratinocytes and increase Ap-1-dependent involucrin transcription. J Invest Dermatol 2000;114:545-53
   PubMed Web of Science ®Google Scholar
• Jiang YJ, Lu B, Kim P, Regulation of ABCA1 expression in human keratinocytes and murine epidermis. J Lipid Res 2006;47:2248-58
   PubMed Web of Science ®Google Scholar
• Chang KC, Shen Q, Oh IG, Liver X receptor is a therapeutic target for photoaging and chronological skin aging. Mol Endocrinol 2008;22:2407-19
   PubMedGoogle Scholar
• Hatano Y, Man MQ, Uchida Y, Murine atopic dermatitis responds to peroxisome proliferator-activated receptors alpha and beta/δ (but not gamma) and liver X receptor activators. J Allergy Clin Immunol 2010;125:160-9 e1-5
   PubMed Web of Science ®Google Scholar
• Steffensen KR, Robertson K, Gustafsson JA, Reduced fertility and inability of oocytes to resume meiosis in mice deficient of the Lxr genes. Mol Cell Endocrinol 2006;256:9-16
   PubMed Web of Science ®Google Scholar
• Drouineaud V, Sagot P, Garrido C, Inhibition of progesterone production in human luteinized granulosa cells treated with LXR agonists. Mol Hum Reprod 2007;13:373-9
   PubMed Web of Science ®Google Scholar
• Marceau G, Volle DH, Gallot D, Placental expression of the nuclear receptors for oxysterols LXRalpha and LXRbeta during mouse and human development. Anat Rec A Discov Mol Cell Evol Biol 2005;283:175-81
   PubMedGoogle Scholar
• Henry-Berger J, Mouzat K, Baron S, Endoglin (CD105) expression is regulated by the liver X receptor alpha (NR1H3) in human trophoblast cell line JAR. Biol Reprod 2008;78:968-75
   PubMed Web of Science ®Google Scholar
• Mouzat K, Prod'homme M, Volle DH, Oxysterol nuclear receptor LXRbeta regulates cholesterol homeostasis and contractile function in mouse uterus. J Biol Chem 2007;282:4693-701
   PubMed Web of Science ®Google Scholar
• Frenoux JM, Vernet P, Volle DH, Nuclear oxysterol receptors, LXRs, are involved in the maintenance of mouse caput epididymidis structure and functions. J Mol Endocrinol 2004;33:361-75
   PubMed Web of Science ®Google Scholar
• Saez F, Chabory E, Cadet R, Liver X receptors and epididymal epithelium physiology. Asian J Androl 2007;9:574-82
   PubMed Web of Science ®Google Scholar
• Ouvrier A, Cadet R, Vernet P, LXR and ABCA1 control cholesterol homeostasis in the proximal mouse epididymis in a cell-specific manner. J Lipid Res 2009;50:1766-75
   PubMed Web of Science ®Google Scholar
• Rough JJ, Monroy MA, Yerrum S, Anti-proliferative effect of LXR agonist T0901317 in ovarian carcinoma cells. J Ovarian Res 2010;3:13
   PubMed Web of Science ®Google Scholar
• Vedin LL, Lewandowski SA, Parini P, The oxysterol receptor LXR inhibits proliferation of human breast cancer cells. Carcinogenesis 2009;30:575-9
   PubMed Web of Science ®Google Scholar
• Kim KH, Yoon JM, Choi AH, Liver X receptor ligands suppress ubiquitination and degradation of LXRalpha by displacing BARD1/BRCA1. Mol Endocrinol 2009;23:466-74
   PubMedGoogle Scholar
• Gronberg H. Prostate cancer epidemiology. Lancet 2003;361:859-64
   PubMed Web of Science ®Google Scholar
• Huggins C, Hodges CV. Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. CA Cancer J Clin 1972;22:232-40
   PubMedGoogle Scholar
• Watanabe M, Nakayama T, Shiraishi T, Comparative studies of prostate cancer in Japan versus the United States. A review. Urol Oncol 2000;5:274-83
   PubMed Web of Science ®Google Scholar
• Magura L, Blanchard R, Hope B, Hypercholesterolemia and prostate cancer: a hospital-based case-control study. Cancer Causes Control 2008;19:1259-66
   PubMed Web of Science ®Google Scholar
• Platz EA, Leitzmann MF, Visvanathan K, Statin drugs and risk of advanced prostate cancer. J Natl Cancer Inst 2006;98:1819-25
   PubMed Web of Science ®Google Scholar
• Shannon J, Tewoderos S, Garzotto M, Statins and prostate cancer risk: a case-control study. Am J Epidemiol 2005;162:318-25
   PubMed Web of Science ®Google Scholar
• Fukuchi J, Kokontis JM, Hiipakka RA, Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells. Cancer Res 2004;64:7686-9
   PubMed Web of Science ®Google Scholar
• Pommier AJ, Alves G, Viennois E, Liver X Receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells. Oncogene 2010;29:2712-23
   PubMed Web of Science ®Google Scholar
• Fukuchi J, Hiipakka RA, Kokontis JM, Androgenic suppression of ATP-binding cassette transporter A1 expression in LNCaP human prostate cancer cells. Cancer Res 2004;64:7682-5
   PubMed Web of Science ®Google Scholar
• Kim HJ, Andersson LC, Bouton D, Stromal growth and epithelial cell proliferation in ventral prostates of liver X receptor knockout mice. Proc Natl Acad Sci USA 2009;106:558-63
   PubMed Web of Science ®Google Scholar
• Farnegardh M, Bonn T, Sun S, The three-dimensional structure of the liver X receptor beta reveals a flexible ligand-binding pocket that can accommodate fundamentally different ligands. J Biol Chem 2003;278:38821-8
   PubMed Web of Science ®Google Scholar
• Poujol N, Wurtz JM, Tahiri B, Specific recognition of androgens by their nuclear receptor. A structure-function study. J Biol Chem 2000;275:24022-31
   PubMed Web of Science ®Google Scholar
• Mouzat K, Alves G, Pommier A, Nuclear liver X receptors are involved in the biology of reproduction. Med Sci (Paris) 2009;25:141-4
   PubMed Web of Science ®Google Scholar